Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by thadeushon May 27, 2017 1:18pm
173 Views
Post# 26292160

RE:Efficacy is a no-brainer

RE:Efficacy is a no-brainerAll the more reason why Theralase's safe, effective and mercifully brief treatment will be a massive success! Thanks for pointing out the difference. They've already (on schedule and as promised) proved the safety part (or was the reading level too high for you?), now they are moving deliberately and relentlessly to the efficacy

I'm not in this because it's like the other 92%, I'm in it because these guys are on the job:

https://theralase.com/about-us/ 

and they're doing this stuff:

https://www.youtube.com/channel/UC4NAFPiFj2g1O6zeBLj5hfg (Therlase Channel on YouTube)

so we can help cancer sufferers and make (massive) money. 
Bullboard Posts